Q3 2024 · 13F-HR
STEMPOINT CAPITAL LPholdings as filed
Filed 2024-11-13 · accession 0001420506-24-002386
$334.0M
Reported value
54
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $33.3M | 9.98% | 1,731,191 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $32.0M | 9.57% | 2,769,819 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $21.0M | 6.30% | 421,222 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $19.1M | 5.73% | 671,001 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $16.5M | 4.95% | 1,778,318 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $15.8M | 4.74% | 1,481,809 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $14.2M | 4.26% | 275,303 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $13.2M | 3.96% | 1,554,586 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $10.9M | 3.27% | 213,815 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $10.8M | 3.24% | 216,440 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $10.0M | 3.00% | 174,034 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $9.5M | 2.84% | 2,616,602 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $8.6M | 2.56% | 129,490 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $8.2M | 2.46% | 282,050 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $7.1M | 2.11% | 506,978 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $6.5M | 1.95% | 1,317,854 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $6.2M | 1.86% | 123,177 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $6.0M | 1.81% | 1,278,444 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $5.1M | 1.54% | 449,735 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $5.0M | 1.51% | 86,930 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $5.0M | 1.50% | 60,076 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $4.9M | 1.47% | 1,846,792 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $4.6M | 1.37% | 203,015 | Common | SOLE |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $4.3M | 1.28% | 860,951 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $4.2M | 1.27% | 1,044,168 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $4.2M | 1.26% | 132,703 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $3.7M | 1.12% | 449,321 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.2M | 0.95% | 238,084 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $3.1M | 0.93% | 850,210 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $3.1M | 0.92% | 73,299 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $3.1M | 0.92% | 241,984 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $2.5M | 0.76% | 743,719 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $2.5M | 0.74% | 300,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.4M | 0.72% | 94,885 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $2.2M | 0.67% | 49,415 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $2.2M | 0.66% | 182,918 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.2M | 0.65% | 41,268 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.1M | 0.63% | 200,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $1.9M | 0.56% | 15,014 | Common | NONE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $1.7M | 0.52% | 942,857 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $1.5M | 0.45% | 150,000 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.4M | 0.43% | 55,523 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $1.4M | 0.43% | 93,638 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 0.41% | 48,918 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $1.3M | 0.40% | 83,662 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $1.3M | 0.39% | 50,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $763,699 | 0.23% | 14,464 | Common | NONE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $755,259 | 0.23% | 16,654 | Common | NONE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $618,876 | 0.19% | 56,287 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $531,131 | 0.16% | 19,900 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $381,750 | 0.11% | 230,000 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $112,500 | 0.03% | 200,000 | CALL | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $75,480 | 0.02% | 251,600 | CALL | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $12,500 | 0.00% | 250,000 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.